We cloned two isoforms of the Xenopus Eya1 orthologue. They show identical patterns of expression that closely resemble the previously described expression of XSix1, but partly differ from the expression of Eya1 in other vertebrates. XEya1 is expressed in the somites and hypaxial muscle precursors, but not in the pronephros. Moreover, all ectodermal placodes except the lens placode strongly express XEya1. At neural plate stages, ectodermal XEya1 expression starts in two domains, the anterior neural folds and a domain lateral to the neural folds. At tailbud stages, XEya1 expression continues in the adenohypophysis, all neurogenic placodes and placodally-derived structures including cranial ganglia, the otic vesicle and lateral line primordia. q
Results and discussion
The Eya genes comprise a family of genes homologous to eyes absent, which is required for normal eye development in Drosophila (Bonini et al., 1993) . Vertebrate Eya1 genes are expressed in multiple domains including many ectodermal placodes (Sahly et al., 1999; Xu et al., 1997a; Abdelhak et al., 1997) , and they play important roles in mammalian ear and kidney development (Xu et al., 1999; Johnson et al., 1999) . To further study the role of Eya1 in placodal development, we isolated the cDNAs encoding two Xenopus Eya1 isoforms (XEya1a and XEya1b; Acc. Nos. AF352028 and AF352029, GenBank) via a PCR-based approach. The deduced XEya1a protein consists of 587 amino acids, whereas a 15 bp insertion at the N-terminus leads to the longer XEya1b variant containing 592 amino acids (Fig. 1A) . The high degree of amino acid identity (85%) to other known vertebrate Eya1 proteins con®rms the expected Xenopus Eya1 homologues (Fig. 1B) . Characteristic of the Eya family, the highest overall similarity is observed in the so called C-terminal Eya domain (Fig. 1A) . Interestingly, the above mentioned 15 bp insertion corresponding to XEya1b is present in both known mammalian Eya1 forms, whereas the zebra®sh homologue lacks this insert (Fig. 1A) .
Both Xenopus Eya1 isoforms are expressed in indistinguishable patterns. Using RT-PCR, XEya1 transcripts were ®rst visible in gastrulae (stage 10), and increased up to tadpole stages (Fig. 2) . At neural plate stages, in situ hybridization reveals XEya1 expression in an ectodermal domain lateral to the neural folds, which will give rise to profundal/ trigeminal, dorsolateral and possibly epibranchial placodes (Schlosser and Northcutt, 2000) (Fig. 3A) . At neural fold stages, the anterior neural folds comprising the anlagen of olfactory placodes and adenohypophysis (Eagleson and Harris, 1990; Eagleson et al., 1995) also express XEya1 (Fig. 3B) . At tailbud stages, ectodermal XEya1 expression broadens (Fig. 3C,D) and becomes localized to the adenohypophysis and all neurogenic placodes (i.e. profundal/ trigeminal, olfactory, otic, lateral line, epibranchial and hypobranchial placodes; Knouff, 1935; Schlosser and Northcutt, 2000) (Figs. 3E and 4B, E) , as well as to placodally-derived structures including cranial ganglia, otic vesicle and lateral line primordia (Figs. 3F and 4B, E) . However, neither the lens placode nor the lens ever express XEya1.
Ectodermal Eya1 expression in Xenopus differs from other vertebrates. While widespread placodal Eya1 expression has also been reported for teleosts (Sahly et al., 1999; Ko Èster et al., 2000) and mice (Xu et al., 1997a; Abdelhak et al., 1997; Kalatzis et al., 1998) , the presence of expression in epibranchial placodes has only been determined for mouse embryos. Moreover, Eya1 is not expressed in profundal and trigeminal placodes of either zebra®sh or mouse embryos, while being expressed in the mouse lens placode. The more extensive expression of XEya1 in neurogenic placodes corresponds to the combined expression domains of mouse Eya1 and Eya2 (Duncan et al., 1997; Xu et al., 1997a) , suggesting complementary evolutionary losses (Force et al., 1999) of expression domains of the two paralogues in different lineages.
XEya1 expression is also observed in somites and hypaxial muscle precursors (Figs. 3D,E and 4B), similar to other vertebrates (Xu et al., 1997a,b; Sahly et al., 1999) . However, XEya1 is not expressed in the pronephros or pronephric duct (Fig. 3C±F ), similar to zebra®sh (Sahly et al., 1999) , whereas in mammals Eya1 is expressed in the developing kidney (Xu et al., 1997a (Xu et al., , 1999 Abdelhak et al., 1997; Kalatzis et al., 1998) . Additionally, XEya1 is expressed in a few scattered cells in the brain and retina, and in the pharyngeal pouches (Fig. 4E) .
Comparison with other placodal markers such as XSix1 (Pandur and Moody, 2000) (Fig. 4A,D) and XSox2 (Mizuseki et al., 1998; La Bonne and Bronner-Fraser, 1998) (Fig.  4C,F ) con®rmed placodal expression of XEya1. Moreover, expression of XSix1 and XEya1 is largely identical in placodes as well as in somites and hypaxial muscle precursors. Taken together with previous observations (Oliver et al., 1995; Ohto et al., 1998; Esteve and Bovolenta, 1999; Relaix and Buckingham, 1999; Kobayashi et al., 2000; Kawakami et al., 2000) , this suggests that Eya1 and/or Eya2 is co-expressed with Six1 and/or Six4 throughout vertebrates.
Experimental procedures

Cloning of Xenopus laevis Eya1 isoforms
A 722 bp and a 707 bp fragment of XEya1 were obtained using degenerate primers for Eya1 and cloned into pTAdv (Clontech). Speci®c primers were then used for Race-PCRs (Marathon-kit, Clontech) using proof reading polymerase and stage 35 cDNAs. Cloning was performed via a PCRcloning-kit (Clontech). A number of clones contained the 5 or 3 H ends of XEya1. Full-length Race-PCR led to various clones with the entire reading frame representing two XEya1 isoforms.
RT-PCR
XEya1 and EF1a fragments were ampli®ed as described (pAV, pAD, pM, pP) , epibranchial (epVII, epIX, epX1, epX2/3) and hypobranchial placodes (hp1). Co-expression of both genes is also observed in cranial ganglia that have a placodally-derived component, e.g. in the profundal/ trigeminal ganglionic complex (data not shown), in the fused ganglia of the facial, anteroventral and anterodorsal lateral line nerves (gVII/AV/AD in D,E), and in the fused ganglia of the glossopharyngeal and middle lateral line nerves (gIX/M in D,E). Additionally, XEya1 and XSix1 are co-expressed in the somites (s in A,B), in hypaxial muscle precursors (white arrowheads in A,B) and weakly in the pharyngeal pouches (asterisks in D,E). Placodal expression of XSox2 (C,F) overlaps with the expression of XEya1 and XSix1 in the adenohypophysis (data not shown), the olfactory placode, the otic vesicle and the lateral line placodes, as well as in some cranial ganglia (e.g. gVII/AV/AD in F). In contrast to XEya1 and XSix1, however, XSox2 is not expressed in the profundal/trigeminal placodes or ganglia (data not shown) and in the epibranchial placodes (C), whereas it is strongly expressed in the neural tube (nt), the lens (l), and the pharyngeal pouches (asterisks). Bar in (A): 0.1 mm (A±C). Bar in (D): 0.1 mm (D±F). , an ectodermal domain (arrow) lateral to the neural folds expresses XEya1. (B) At neural fold stages (stage 18; insert, same specimen in oblique anterior view) this domain has separated into a profundal/trigeminal placodal area (pPrV) and a posterior placodal area (pp). The latter corresponds to the`dorsolateral placodal area' of Schlosser and Northcutt (2000) , but has been assigned a more neutral label here, because XEya1 expression suggests that it may be the precursor not only of lateral line and otic placodes but also of epibranchial placodes. XEya1 also starts to be expressed in the anterior placodal area (ap) of the anterior neural folds, the precursor of adenohypophysis and olfactory placodes. (C) At early tailbud stages (stage 22), XEya1 expression is maintained in the olfactory placodes (pOl), the developing adenohypophysis (data not shown), and the profundal/trigeminal placodal area. Within the posterior placodal area of XEya1 expression, it is now possible to distinguish the otic placode (pOt) and two ventral extensions. The anterior extension (app) is closely apposed to the profundal/trigeminal placodal area. It will give rise to the anterodorsal and anteroventral lateral line placodes and the facial epibranchial placode. The posterior extension (ppp) will broaden later and give rise to the remaining lateral line, epibranchial and hypobranchial placodes. (D) At mid-tailbud stages (stage 26), XEya1 continues to be expressed in the shrinking profundal and trigeminal placodes (pPrV), in the otic vesicle (vOt), in the anterodorsal (pAD) and anteroventral (pAV) lateral line placode, as well as in the facial epibranchial placode (epVII). The apparently contiguous XEya1 expression domain anterior to the otic vesicle re¯ects the close apposition of these placodes (Schlosser and Northcutt, 2000) . The middle (pM) lateral line placode and the developing glossopharyngeal (epIX) epibranchial placode but not the lens placode (lp) also express XEya1. Moreover, XEya1 transcripts are now detectable in the somites (s). (E) At stage 30, XEya1 is expressed in all neurogenic placodes, including the newly developed posterior lateral line placode (pP), vagal epibranchial placodes (epX1 and epX2/3), and hypobranchial placodes (hp1), in the somites and in the hypaxial muscle precursors (white arrowheads), but not in the lens (l). (F) At early tadpole stages (stage 41), XEya1 expression persists in placodally-derived structures such as the otic vesicle (vOt) and in the primordia of lateral lines derived from the anterodorsal (e.g. supraorbital line, so), anteroventral (e.g. hyomandibular line, hm; other lines, asterisk), middle (e.g. aortic lateral line, ao), and posterior lateral line placodes (dorsal, middle and ventral trunk lines, d, m, v) . The XEya1 positive hypaxial muscle precursors (white arrowheads) have migrated further ventrally. Bar in (A): 0.1 mm (A±F).
